Home › Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension
 

Keywords :   


Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension

2015-08-25 23:15:17| Biotech - Topix.net

The iShares NASDAQ Biotechnology Index ETF fell another 4% on Monday and is now down more than 11% in the last three trading sessions amid a selloff in the broader market. Not surprisingly, the question every biotech focused investor is asking right now is whether this is an opportunity to buy.

Tags: extension stocks prospects digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 25A
05.07Summary for Hurricane Beryl (AT2/AL022024)
05.07Amazon at 30: What next for 'The Everything Company'?
05.07Atlantic Tropical Weather Outlook
05.07Could the 'flying piano' help transform air cargo?
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
More »